An evaluation of becotatug vedotin for the treatment of recurrent or metastatic nasopharyngeal cancer
ABSTRACT Introduction Recurrent or metastatic nasopharyngeal carcinoma (R/M NPC) remains a significant clinical challenge despite advances in chemoradiation, with approximately 30% of patients ultimately developing R/M disease. There is an ongoing unmet need for novel therapeutic approaches that improve outcomes in thi...